However, in advanced HCC, tumor-derived signals—including TGF-β and granulocyte-macrophage colony-stimulating factor (GM-CSF)—reprogram N1 TANs toward the N2 phenotype (273). The gene discussed is CSF2; the disease is neoplasm.